Trevi Therapeutics (TRVI) News Mentions Statistics 2025

00%

1W 0% 1M 0% 3M 0%

Est. daily news mentions.

Similar companies

Company		News Mentions
	Amgen AMGN	3 200%
	Gilead Sciences GILD	2 0%
	Catalyst Pharmaceuticals CPRX	2 0%
	Inovio Pharmaceuticals INO	1 0%
	Anavex Life Sciences AVXL	0 100%

D. Boral Capital Reaffirms Buy Rating for Trevi Therapeutics (NASDAQ:TRVI)

January 10

What Makes Trevi Therapeutics (TRVI) a New Buy Stock

January 8

Trevi Therapeutics Announces Company Updates Ahead of 14th Annual LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference

January 7

Geode Capital Management LLC Acquires 117,418 Shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI)

January 6

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives $9.31 Average Target Price from Analysts

January 4

BNP Paribas Financial Markets Acquires 6,764 Shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI)

December 20

Month over Month

Est. daily news mentions.

Dec 2024	0	141.9%
Nov 2024	0	58.7%
Oct 2024	0	61.3%
Sep 2024	0

How often is Trevi Therapeutics mentioned in the news?

Trevi Therapeutics was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Trevi Therapeutics performing compared to its industry peers?

Trevi Therapeutics underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Trevi Therapeutics in the last month?

There has been no significant change in the number of news mentions for Trevi Therapeutics 's compared to the last month.

Why is it important to track news mentions for Trevi Therapeutics ?

By monitoring mentions in the news for Trevi Therapeutics , investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Trevi Therapeutics , ultimately improving their investment strategies.

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

Top Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact

Trevi Therapeutics (TRVI) - News Mentions